AI-generated analysis. Always verify with the original filing.
For Q3 2026 (period ending December 31, 2025), the company reported net sales of $964K, cost of goods sold of $674K, and gross profit of $289K. Operating expenses totaled $2.1M, resulting in a loss from operations of -$1.8M. Total other income (expense) was -$865K, and total provision for income tax was $23K, leading to a net loss of -$2.7M. The balance sheet shows total assets of $6.4M, total liabilities of $9.3M, and total stockholders' deficit of -$3.0M. Cash flow from operating activities was -$5.5M, from investing activities was -$87K, and from financing activities was $6.2M, resulting in a net increase in cash of $597K and cash at end of period of $478K. No prior period data is provided for comparison.
For Q3 2026 (period ending December 31, 2025), the company reported net sales of $964K, cost of goods sold of $674K, and gross profit of $289K. Operating expenses totaled $2.1M, consisting of selling expenses of $734K, general and administrative expenses of $1.2M, and research and development expenses of $227K, resulting in a loss from operations of -$1.8M. Total other income (expense) was -$865K, including interest income of $272, other income of $5K, loss on extinguishment of debt of -$123K, and interest expense of $871K. Total provision for income tax was $23K, comprising enterprise income tax expense of $53 and Delaware franchise tax of $23K. Share of gain (loss) in joint venture was $70. Net loss was -$2.7M. Weighted average common shares outstanding were 30.8M basic and diluted, with net loss per share of -$0 basic and diluted. No prior period data is provided for comparison.
No segment breakdown, geographic mix, or growth drivers are disclosed in the provided data.
Gross margin was 30.0% ($289K gross profit / $964K net sales). Operating margin was -186.7% (-$1.8M loss from operations / $964K net sales). The cost structure shows cost of goods sold of $674K and operating expenses of $2.1M, with selling expenses of $734K, general and administrative expenses of $1.2M, and research and development expenses of $227K.
Cash flow from operating activities was -$5.5M, with net loss of -$2.7M and adjustments including depreciation and amortization expense of $467K. Cash flow from investing activities was -$87K, with cash paid for purchases of property and equipment of $85K and intangibles of $2K. Cash flow from financing activities was $6.2M, including issuance of preferred stock of $1.9M, proceeds from SAFE notes of $3.6M, and proceeds from convertible notes of $3.0M. Net increase in cash was $597K, with cash at end of period of $478K. Total assets were $6.4M, including current assets of $3.4M (cash and cash equivalents of $1.1M) and noncurrent assets of $2.9M. Total liabilities were $9.3M, including current liabilities of $8.7M (current portion of notes payable of $5.3M) and long-term liabilities of $564K. Stockholders' deficit was -$3.0M, with accumulated deficit of -$69.4M.
No management guidance, strategic priorities, or risk factors are disclosed in the provided data.
EPS
-$0
Revenue
$964K
Net Income
-$2.7M
Gross Margin
30.0%
Gross Profit
$289K
Operating Income
-$1.8M
operating margin
-186.7%